| Bioactivity | FFA1 agonist-1 (Compound 17a) is an orally active fatty acid receptor 1 (FFA1) agonist with an EC50 of 0.75 μM. FFA1 agonist-1 can be used for type 2 diabetes mellitus research[1]. |
| Target | EC50: 0.75 μM (FFA1) |
| In Vivo | FFA1 agonist-1 (Compound 17a) (0-25 mg/kg; p.o.) reduces the plasma glucose levels in a dose-dependent manner in mice[1]. |
| Name | FFA1 agonist-1 |
| CAS | 2417231-16-2 |
| Formula | C27H36ClNO3 |
| Molar Mass | 458.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kuranov SO, et al. Exploring bulky natural and natural-like periphery in the design of p-(benzyloxy)phenylpropionic acid agonists of free fatty acid receptor 1 (GPR40). Bioorg Chem. 2020 Jun;99:103830. |
FFA1 agonist-1
CAS: 2417231-16-2 F: C27H36ClNO3 W: 458.03
FFA1 agonist-1 (Compound 17a) is an orally active fatty acid receptor 1 (FFA1) agonist with an EC50 of 0.75 μM. FFA1 ag
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.